Publicidad
Caso clínico 14 de agosto de 2013

Histiocitosis de células de Langerhans en el adulto: aporte del PET-CT con 18F-FDG

Referenciar Imprimir Descargar PDF

Referencias

  1. Murcia Gándara J, Bárcenas W. Histiocitosis. Sociedad Colombiana de Pediatría – CCAP, Volumen 11 Número 4.
  2. National Cancer Institute. Langerhans Cell Histiocytosis. Treatment PDQ. Last modified 05/22/2013 (available at http://www.cancer.gov/cancertopics/pdq/ treatment/lchistio/HealthProfessional).
  3. Histiocyte Society. Evaluation and treatment guidelines. April 2009. (available at: www.histiocytesociety.org).
  4. Aricò M, Girschikofsky M, Généreau T, et al. Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society. Eur J Cancer 2003;39:2341-8.
  5. Kaltsas GA, Powles TB, Evanson J, et al.: Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J Clin Endocrinol Metab 2000;85:1370-6.
  6. Kaste SC, Rodriguez-Galindo C, McCarville ME, Shulkin BL. PET-CT in pediatric Langerhans cell histiocytosis. Pediatr Radiol 2007;37:615–22.
  7. Phillips M, Allen C, Gerson P, McClain K. Comparison of FDG- PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 2009;52:97–101.
  8. Mueller WP, Melzer HI, Schmid I, et al. The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging 2013;40:356-63.
  9. Lee HJ, Ahn BC, Lee SW, Lee J. The usefulness of F-18 fluoro- deoxyglucose positron emission tomography/computed tomography in patients with Langerhans cell histiocytosis. Ann Nucl Med 2012;26:730–7.